Objective: MicroRNA (miRNA) expression is deregulated in many types of human cancers. We sought to investigate the expression patterns of the miRNAs, miR-21, miR-145 and miR-155 in sporadic gastric cancer in a Chinese population. Methods: Total RNA was extracted from archived gastric cancer tissues and adjacent non-cancerous tissues from 20 pairs of paraffin-embedded specimens. Expression levels of miR-21, miR-145 and miR-155 were detected by quantitative reverse transcriptase PCR using a specific stem-loop primer, with U6 as the internal reference gene. Results: The expression of miR-21 and miR-155 in gastric cancer samples was significantly higher than in paired non-cancerous samples (P < 0.05). There was no statistically significant difference in expression levels of miR-145 between cancerous and non-cancerous tissues (P > 0.05). Conclusion: In Chinese sporadic gastric cancer tissues, the expressions of the oncogenic miR-21 and miR-155 were significantly up-regulated, while the expression of the tumor suppressor miR-145 was decreased, although this decrease was not statistically significant. Thus there is specificity in the miRNA expression pattern in gastric cancers in the Chinese population.
INTRODUCTION
MicroRNAs (miRNAs) are small, non-coding RNAs of 19-24 nucleotides in length that were first reported by Lee and colleagues [1] . Sequences of miRNAs are highly conserved [2] , and they regulate gene expression at a post-transcriptional level, most commonly by inhibiting mRNA translation or promoting mRNA degradation [3] . miRNAs are frequently misregulated in human malignancies [4] . Over the past 10 years, many findings have strongly supported a role for miRNAs in the regulation of crucial processes such as cell proliferation [5] , apoptosis [6] , development [7] , differentiation [8] and metabolism [9] . Therefore, miRNAs dysfunction may contribute to a variety of human diseases such as cancer, cardiovascular disease, liver disease, immune dysfunction and metabolic disorders [10] . The first evidence that miRNAs were involved in cancer came from the finding that miR-15a and miR-16-1 were down-regulated or deleted in most patients with chronic lymphocytic leukemia [11] . In tumor diseases, miRNAs may act as oncogenes or tumor suppressor genes, and sometimes both [12, 13] . miRNAs may be used as molecular markers for early diagnosis and prognosis of cancer. In a study by Yanihara et al [14] , microarray analysis identified unique miRNA expression profiles which could discriminate between cancerous and non-cancerous lung tissue. Similarly, in breast tumors a reduced expression of let-7a correlated with bad prognosis, characterized by lymph node metastasis and a high proliferative index [15] . These findings demonstrate that expression analyses of miRNAs in neoplastic cells are of significance for diagnosis of tumor malignancy and subsequent patient outcome.
According to data from 2002, stomach cancer was the second most common form of cancer worldwide and the second most common cause of cancerous mortality. Almost two-thirds of cases occurred in developing countries, of which 42% occurred in China alone [16] . These data highlight the current need for further research into gastric cancer, particularly in China. While some studies on the relationship between miRNAs and gastric cancer have recently been done (reviewed by Saito et al [17] ), little work [18] [19] [20] [21] has been carried out in China. It is important to note that differential gene expression may occur among different ethnic groups [22, 23] as well as within ethnic groups of different spatial localization [24] and within different individuals of the same race [25] . From a Chinese health perspective, studies into the relationship between miRNAs and Chinese sporadic gastric cancer could provide valuable information.
In this paper, two potential oncogenic miRNAs (miR-21 and miR-155) and one potential tumor suppressor miRNA (miR-145) [12, 17] were chosen to investigate the relationship between miRNA expression level and Chinese gastric cancer, with the aim of elucidating possible differences in miRNA expression patterns within the Chinese population.
MATERIALS AND METHODS

Samples
All samples were obtained from patients who had undergone surgical gastric resection at the Affiliated Hospital of Nanjing University of Traditional Chinese Medicine. Twenty paired samples were selected randomly and examined independently by two experienced pathologists. The samples were gastric cancer tissues and adjacent non-cancerous tissues in the same patient. Patients all came from Jiangsu Province and Anhui Province in China and each patient gave his/her informed consent. A summary of the pathological characteristics of these patients is given in Table 1 . The average age of the patients was 51.9 years (range 40-71).
Total RNA extraction
RNA was isolated f rom formaldehyde-fixed paraffin-embedded (FFPE) tissues with RecoverAll™ Total Nucleic Acid Isolation Kit (Ambion USA) which is designed to extract total nucleic acids (RNA, miRNA, and DNA) from FFPE tissues. Up to four 20 μm sections, or up to 35 mg of unsectioned core samples were processed per reaction. Paraffin was removed with 100% xylene, and the pellet was washed twice with 1 ml of 100% ethanol and air-dried. After addition of 400 μl digestion buffer and 4 μl protease, the sample was incubated at 50 °C for 3 h. Isolation additive (480 μl) and ethanol (1.1 ml) were added, and the samples passed through a filter cartridge. The filter cartridge was washed with 700 μl wash 1 solution and 500 μl wash 2/3 solution, and then was centrifuged to remove residual fluid. DNase mix was added to each filter cartridge and incubated for 30 min. After being washed once with 700 μl wash 1 solution and twice with 500 μl of wash 2/3 solution, the sample was centrifuged to remove residual fluid. Samples were eluted in 60 μl elution solution at room temperature. RNA concentration and purity were quantified by spectrophotometry (A260/280 value of about 2.0).
Reverse transcription and real-time PCR
Quantification of expression levels of miRNAs was done using a two-step RT-PCR method. The PCR primer pairs for miR-21, miR-145 and miR-155 were obtained commercially from Applied Biosystems (Applied Biosystems, ABI, USA). cDNA was reverse transcribed from total RNA samples using specific miRNA primers from the TaqMan MicroRNA Assays (ABI, USA) and reagents from the TaqMan® MicroRNA Reverse Transcription Kit (ABI, USA). Real-time PCR was performed using the TaqMan MicroRNA Assay together with the TaqMan® Universal PCR Master Mix (ABI, USA). Twenty mocroliter real-time PCR reactions included 1.33 μl RT product dilution (1:15), 10 μl 2×Taqman® Universial PCR Master Mix, 1 μl 20×PCR primer (TaqMan® MicroRNA Assays; ABI), and 7.67 μl nuclease-free water. U6 was used as an internal control to normalize the expression levels of target genes by correcting differences in the amount of cDNA loaded into PCR reactions. The real-time PCR began with an initial denaturation step at 95 °C for 10 min, 50 cycles of 15 s at 95 °C, 1 min at 60 °C. All reactions were run in triplicate using the ABI 7900 HT Fast Real-Time PCR System with SDS software (version 2.3, ABI), and average threshold cycle number (Ct) data of each miRNA was analyzed with RQ Manager software (Version 1.2, ABI).
The ΔCt method [26] and 2 -ΔΔCt method [27] were used for analysis. The ΔCt value was the difference between the Ct value of the specific miRNA and the Ct value of U6, ΔCt = Ct (miRNA)-Ct (U6). ΔΔC t= ΔCt (cancer tissues) -ΔCt (non-tumor tissues). The value of 2 -ΔCt represents miRNA expression or content of each sample [28] . The value of 2 -ΔΔCt represents the expression relative quotient (RQ) of target gene to the control gene. Here, RQ showed the value of miRNA expression ratio in cancerous tissue to that in adjacent noncancerous tissue. An RQ <1 indicates that expression levels of miRNAs in cancerous tissue are lower than that in non-cancerous tissue. Conversely, an RQ >1 indicates higher miRNA expression in cancerous tissue compared to non-cancerous tissue.
Statistical analysis
The data were analyzed with SPSS software (Version 12.0, SPSS Inc., USA). The paired samples t test was used to compare the content of miRNAs in cancerous tissues and adjacent normal tissues. The Pearson test and Spearman rank test were applied to analyze the correlation of RQ values for the three miRNAs. The Mann-Whitney U test and KruskalWallis test were used to evaluate the correlation between miRNA change and clinicopathological parameters. P < 0.05 was considered to be statistically significant.
RESULTS
Ct values of three miRNAs from the paired gastric tissue samples In each cancerous tissue sample of the 20 cases, the Ct value of miR-21 was less than that of miR-155. In non-cancerous tissues of the 20 cases, the Ct value of miR-145 was less than that of miR-155. The Ct value of miR-21 was less than that of miR-155, except one case (data test undetermined) in non-cancerous tissues, and the Ct value of miR-145 was less than that of miR-155 in the cancerous tissue of 19 cases. 8 (40) 12 (60) 11 (55) 9 (45) 15 (75) 4 (20) 1 (5) 4 (20) 4 (20) 12 (60) 3 (15) 3 (15) 12 (60) 2 (10) 6 (30) 7 (35) 7 (35) 9 (45) 10 ( , and the content of miR-21 in cancerous tissues was significantly higher than that in non-cancerous tissues (P = 0.012) ( Table 2) .
miR-145 expression of paired cancerous and non-cancerous samples -ΔCt and 2
-ΔCt values of miR-145 of non-cancerous and cancerous tissue are presented in Fig. 3 . ΔCt = Ct (miR-145) -Ct (U6) . Fig. 3 shows that the miR-145 content of 12 of 20 pairs (60%) was decreased in cancerous tissues compared to non-cancerous tissues from the same patients. The average ΔCt and the average miR-145 content (2 -ΔCt ) for non-cancerous and cancerous gastric tissues were -2.137 and -1.640, and 11.924 and 6.215, respectively. The expressed miR-145 content in cancerous tissues was 0.521 that in non-cancerous tissues (Fold=2 . The content of miR-145 in cancerous tissues was, however, not significantly lower than that in non-cancerous tissues (P = 0.134) ( Table  2) . These results mean that miR-145 expressions in non-cancerous and cancerous gastric tissue were not significantly different. But, in general, the expression of miR-145 in tumor tissue (6.215) was lower than that in non-cancerous tissue (11.924).
miR-155 expression of paired cancerous and non-cancerous samples
The -ΔCt and 2 . The content of miR-155 in cancerous tissues was significantly higher than that in non-cancerous tissues (P = 0.022) ( Table 2) . values of miR-21,-145 and -155 were compared with each other by paired samples t test (two-tailed) in cancerous tissues or non-cancerous tissues respectively. In cancerous tissues, the content of miR-21 was significantly higher than that of miR-145 and miR-155 (P = 0.001, P = 0.001, respectively), and the content of miR-145 was significantly higher than that of miR-155 (P = 0.004). In gastric non-cancerous tissues, the content of miR-21 and miR-145 were significantly higher than that of miR-155 (P = 0.001, P= 0.003, respectively), but there was no difference between the content of miR-21and that of miR-145 (P = 0.123).
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DISCUSSION
T he relati onship betw een al terat ion in the expression of miRNAs and gastric cancer is a challenging issue for researchers. Zhang et al [29] found that the expression level of let-7a miRNA in gastric tumor tissues was significantly reduced when compared to normal tissues in 14 samples from 32 patients. miRNA expression profiling revealed a limited set of miRNAs with altered expression in the multidrugresistant (MDR) gastric cancer cell line SGC7901/ VCR compared to its parental SGC7901 cell line [30] . Also, some research has been directed at targeting the sites of such miRNAs. Motoyama et al [31] found that expression of the high mobility group A2 (HMGA2) non-histone chromosomal protein in cancerous tissues was significantly higher than in non-cancerous tissues and HMGA2 expression status was an independent prognostic factor. An inverse correlation between HMGA2 and let-7a was found in gastric cancer cell lines. These results suggested that HMGA2 is negatively regulated by the let-7 miRNA family in human gastric cancer. The miR-106b-25 cluster, up-regulated in a subset of human gastric tumors, is activated by E2F1 in parallel with its host gene, Mcm7. In turn, miR-106b and miR-93 regulate E2F1 expression, establishing a miRNA-directed negative feedback loop. The miR-106b-25 cluster is involved in E2F1 posttranscriptional regulation and may play a key role in the development of TGF beta resistance in gastric cancer [32] . Xia et al [30] assumed that miR15b and miR-16 could play a role in the development of MDR in gastric cancer cells, at least in part by modulation of apoptosis via targeting BCL2.
In our experiment, miRNA-21 expression in sporadic gastric tumor tissues was remarkably upregulated relative to the non-tumor tissues, which is consistent with existing reports. miR-21 has frequently been reported to be aberrantly overexpressed in diverse tumors, including gastric cancer [33] and other solid tumors [34] . In the past 3 years, at least 3 direct targets of miR-21 have been identified, with all of them being tumor suppressors: the PTEN phosphatase, the actinbinding protein tropomyosin 1 and the reversioninducing-cystein-rich protein with Kazal motifs. Thus, this single miRNA provides a significant survival advantage to cells upon deregulation [35] . Despite these findings, the role and relevant pathway of miR-21 in gastric carcinogenesis is largely unknown.
I n t h i s s t u d y w e a l s o f o u n d a s i g n i f i c a n t overexpression of miR-155 in sporadic gastric tumor tissue obtained from this Chinese population. Similar results were also found in other studies. Overexpression of miR-155, measured either at the primary or mature transcript level, was described in diffuse large B-cell lymphomas (DLBCL) [36] . A set of seven miRNAs, including miR-155, that were most differentially overexpressed in thyroid tumors vs hyperplastic nodules in surgical samples were validated and shown to provide high accuracy in the detection of thyroid cancer [37] . The miR-155 target genes have not yet been fully elucidated, but many discoveries have given hints to reveal the complete picture. Yin et al [38] found that miRNA-155 was an Epstein-Barr virus-induced gene that modulates Epstein-Barr virus-regulated gene expression pathways. Tumor protein 53-induced nuclear protein 1 expression is repressed by miR-155, and its restoration inhibits pancreatic tumor development [39] . The study of DLBCL found that miR-155 expression was associated with NF-kappaB activity. miR-155 expression segregates with specific molecular subgroups of DLBCL and it is highest in activated B-cell (ABC)-type lymphomas [36] . miR-155 also has an important role in the mammalian immune system, specifically in regulating T helper cell differentiation and the germinal center reaction to produce an optimal T cell-dependent antibody response. miR-155 exerts this control, at least in part, by regulating cytokine production. Highly specific knockouts of miR155 in mice resulted in multiple defects in adaptive immunity [40] . miR-145 has been regarded as a tumor suppressor gene [17, 41] . But, our data showed that there was no significant difference in miR-145 expression between cancerous gastric tissue and non-cancerous gastric tissue from the same patient. Down-regulation of miR-145 expression has been reported in breast cancer [42] , primary liver cancer [43] , colorectal cancer [44] [45] [46] , chronic lymphocytic leukemia, B-cell lymphomas, and Burkitt lymphoma [47] . The treatment of human colon cancer cells with miR-145 caused growth arrest and miR-145 was identified as a miRNA that inhibits the growth of human cancer cells [48] .
In the present study we found that expressions of miR-21, -145 and -155 were not correlated with such factors as age, degree of differentiation, histologic type, lymph node metastasis, or Hp infection. Many studies have been carried out to investigate the relationships between miRNAs and clinical diagnosis and prognosis of different tumors. Differences in the profiles of miRNAs between normal and pathological conditions might be promising as biomarkers in early diagnosis and prognosis [49] . A miR-200 miRNA cluster was reported as a prognostic marker in advanced ovarian cancer [50] . miRNA expression profiles of varying pancreatic tissues have identified a number of differentially expressed miRNAs that seemed to be able to differentiate between three tissues of clinical importance: normal pancreas, chronic pancreatitis, and pancreatic ductal adenocarcinoma [51] . Elevated expression of certain miRNAs, including miRNA-155, in pancreatic tumors is associated with poorer survival [52] . The miR-106a level was significantly associated with gastric tumor stage, size and differentiation, lymphatic and distant metastasis and invasion, and may be a potential biomarker in the diagnosis of gastric carcinomas [53] . All these data indicated that miR-155 was involved in the pathogenesis of gastric cancer. But, in the present study, we did not find such relationships between the expression of the miRNA studied and clinopathologies. This indicates that perhaps much more work is needed to be done to clarify these relationships because even in different individuals of the same race, the gene expressions may vary widely [25] . In this study, there was no significant difference in the miR-145 expression between gastric cancer tissue and paired non-cancerous tissue. This may indicate that miRNA-145 is expressed differently in different racial groups. Reports on the differential expression of genes among different racial groups have been presented for years [22] [23] [24] . It is difficult to find a miRNA with a manner of expression that accurately matches all aspects of a certain kind of cancer. After an analysis of 95 miRNAs, miR-92 was found significantly elevated in plasma of patients with colorectal cancer [54] . Our results also demonstrated that expression of miR-21 and miR-145, whether in gastric cancer tissue or in noncancerous tissue, had a higher abundance than that of miR-155.
Formalin-fixed paraffin-embedded (FFPE) tissue samples were used to carry out this experiment. Tetzlaff et al [55] also proved that FFPE tissue samples were reliable sources for studying miRNA expression. Hoefig et al [56] studied the expressions of 157 miRNAs in fresh frozen samples and parallel FFPE samples with real-time quantitative PCR, and the results showed that miRNA expression patterns were rarely affected by the FFPE treatment. Such methods allow us to access large data banks of archival material [57] . With the technique used here, we also obtained a series of reliable data, because the standard error of each group of Ct values was no more than 1 % of the respective mean Ct value. Therefore, results from the FFPE samples reflect the real miRNA expression information in the samples. Both this study and the referenced experiments prove that it is possible to use the most frequently preserved FFPE specimens on file in hospitals for further large-scale studies of miRNA expression in various diseases.
